We pioneer cutting-edge genotyping solutions to streamline gene editing validation and accelerate the journey from discovery to practical use for Cell & Gene Therapies.
Our flagship product, GeneAbacus, empowers the Cell & Gene Therapy community with a fast, efficient in-house genotyping workflow for precise quantification of gene-editing outcomes. Compatible with standard lab equipment, GeneAbacus delivers accurate, quantitative results on gene-editing efficiency in just five hours. By streamlining validation, it accelerates the transition from editing to functional analysis, offering greater speed and confidence than traditional methods.
We are committed to collaborative innovation, and our integrity ensures that every insight derived from our products is grounded in accuracy and reliability.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Nobels Väg 16, Stockholm,17165,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://countagen.com/
- HQ
- Stockholm
Countagen Questions
Countagen's website is https://countagen.com/
Countagen's LinkedIn profile is https://se.linkedin.com/company/countagen
Countagen has
11 employees.
View email and phone details for 11
employees at Countagen.
Countagen's industry is
Biotechnology Research
Countagen's top competitors are
Molecular Attraction Ab,
Pelago Bioscience Ab,
Rarity Bioscience,
Anocca,
Navinci,
Aplex Bio,
Moligo Technologies,
Moleculent,
Symcel,
Pixelgen Technologies.
Countagen's categories are Biotechnology Research
Countagen's founding year is 2020
